Incorporation of Betulinic Acid into Silica-Based Nanoparticles for Controlled Phytochemical Release

Abstract Drug delivery systems are technologies that have been vastly studied and applied to enhance existing therapies. For example, they allow the use of new approaches to already established drugs to improve the application of compounds with biological interest, such as augmenting their bioavailability. Betulinic acid (BA) is a triterpene that possesses interesting biological properties but its low solubility and low bioavailability have limited its applications. This work shows the obtention of BA and its incorporation process into two types of mesoporous silica, SN1(spherical) and SN2 (rod-shaped). Characterization of these materials through infrared, thermal analysis, scanning electron microscopy, and specific surface areas confirmed the presence of this triterpene in this silica matrix. Characterization of the BA release profile demonstrated that the probable mechanism of SN1 nanoparticles is a zero-order release system, whereas SN2 nanoparticles presented a non-Fickian diffusion. These results show the potential use of these nanoparticles as another approach in drug delivery systems for these types of compounds.

[1]  S. B. Moscardini,et al.  Effect of silica coating on the catalytic activity of maghemite nanoparticles impregnated into mesoporous silica matrix , 2019, Materials Chemistry and Physics.

[2]  L. Khorsandi,et al.  Anti-diabetic effect of betulinic acid on streptozotocin-nicotinamide induced diabetic male mouse model , 2018, Brazilian Journal of Pharmaceutical Sciences.

[3]  Dawei Gao,et al.  Self-Assembly of Stimuli-Responsive Au-Pd Bimetallic Nanoflowers Based on Betulinic Acid Liposomes for Synergistic Chemo-Photothermal Cancer Therapy. , 2018, ACS biomaterials science & engineering.

[4]  D. Gong,et al.  New Insights into the Inhibition Mechanism of Betulinic Acid on α-Glucosidase. , 2018, Journal of agricultural and food chemistry.

[5]  D. Arora,et al.  Therapeutic applications of betulinic acid nanoformulations , 2018, Annals of the New York Academy of Sciences.

[6]  Liziane Marçal,et al.  Photoinitiator and anesthetic incorporation into mesoporous silica , 2018 .

[7]  J. Ríos,et al.  New Pharmacological Opportunities for Betulinic Acid , 2017, Planta Medica.

[8]  Weibo Dai,et al.  Helicteric Acid, Oleanic Acid, and Betulinic Acid, Three Triterpenes from Helicteres angustifolia L., Inhibit Proliferation and Induce Apoptosis in HT-29 Colorectal Cancer Cells via Suppressing NF-κB and STAT3 Signaling , 2017, Evidence-based complementary and alternative medicine : eCAM.

[9]  K. Ciuffi,et al.  Incorporation of anti-inflammatory agent into mesoporous silica , 2016, Nanotechnology.

[10]  R. Silva-Rodrigo,et al.  Role of the Si/Al molar ratio and pH in NIW/MCM41-Al2O3 catalysts for HDS of DBT , 2016 .

[11]  D. Ramjugernath,et al.  Experimental solubility for betulin and estrone in various solvents within the temperature range T = (293.2 to 328.2) K , 2016 .

[12]  S. Ribeiro,et al.  Luminescence properties of Eu-complex formations into ordered mesoporous silica particles obtained by the spray pyrolysis process , 2015, Nanotechnology.

[13]  Julia Xiaojun Zhao,et al.  Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[14]  J. Heino,et al.  Intracellular degradation of multilabeled poly(ethylene imine)-mesoporous silica-silica nanoparticles: implications for drug release. , 2013, Molecular pharmaceutics.

[15]  F. Borcan,et al.  Evaluation and differentiation of the Betulaceae birch bark species and their bioactive triterpene content using analytical FT-vibrational spectroscopy and GC-MS , 2012, Chemistry Central Journal.

[16]  I. Zupkó,et al.  Physico-chemical comparison of betulinic acid, betulin and birch bark extract and in vitro investigation of their cytotoxic effects towards skin epidermoid carcinoma (A431), breast carcinoma (MCF7) and cervix adenocarcinoma (HeLa) cell lines , 2012, Natural product research.

[17]  Mansour Ghaffari Moghaddam,et al.  Biological Activity of Betulinic Acid: A Review , 2012 .

[18]  Sonia Morante-Zarcero,et al.  Preliminary Study of the Anticancer Applications of Mesoporous Materials Functionalized with the Natural Product Betulinic Acid , 2012, ChemMedChem.

[19]  E. H. Faria,et al.  Controlling silicate meso-structures using sucupira oil as a new swelling agent , 2012 .

[20]  Dong Chen,et al.  The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.

[21]  M. Vallet‐Regí,et al.  Phosphorus-containing SBA-15 materials as bisphosphonate carriers for osteoporosis treatment , 2010 .

[22]  S. Ribeiro,et al.  Non-leachable highly luminescent ordered mesoporous SiO2 spherical particles , 2010, Nanotechnology.

[23]  C. Jaffe,et al.  Synthesis and anti-leishmanial activity of heterocyclic betulin derivatives. , 2010, Bioorganic & medicinal chemistry.

[24]  Leaf Huang,et al.  Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.

[25]  M. G. Queiroz,et al.  Betulinic acid, a natural pentacyclic triterpenoid, prevents abdominal fat accumulation in mice fed a high-fat diet. , 2009, Journal of agricultural and food chemistry.

[26]  F. Quignard,et al.  Mesoporosity as a new parameter for understanding tension stress generation in trees. , 2009, Journal of experimental botany.

[27]  K. Ciuffi,et al.  Spherical hybrid silica particles modified by methacrylate groups , 2007 .

[28]  D. Martin,et al.  Nanomedicine , 2005, BMJ.

[29]  B. K. Mishra,et al.  Chemical modification of silica surface by immobilization of functional groups for extractive concentration of metal ions. , 2004, Talanta.

[30]  R. Cichewicz,et al.  Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection , 2004, Medicinal research reviews.

[31]  Younes Messaddeq,et al.  Filmes de titânio-silício preparados por spin e dip-coating , 2003 .

[32]  Geoffrey A. Cordell,et al.  Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis , 1995, Nature Medicine.

[33]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[34]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[35]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[36]  J. R. Cole,et al.  Tumor inhibitory agents from Vauquelinia corymbosa (Rosaceae). , 1976, Journal of pharmaceutical sciences.

[37]  E. Barrett,et al.  The Determination of Pore Volume and Area Distributions in Porous Substances. II. Comparison between Nitrogen Isotherm and Mercury Porosimeter Methods , 1951 .

[38]  Hamid Behrouj,et al.  Betulin and its derivatives as novel compounds with different pharmacological effects. , 2019, Biotechnology advances.

[39]  D. C. Morgan,et al.  Recent Developments on the Synthesis and Applications of Betulin and Betulinic Acid Derivatives as Therapeutic Agents , 2017 .

[40]  Matsunami,et al.  Biological Activity , 2014 .

[41]  Shutao Guo,et al.  Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy , 2011 .

[42]  K. J. Ciuffi,et al.  Fenilsilicato dopado com Eu III obtido pelo método sol-gel , 2007 .

[43]  E. Barrett,et al.  (CONTRIBUTION FROM THE MULTIPLE FELLOWSHIP OF BAUGH AND SONS COMPANY, MELLOX INSTITUTE) The Determination of Pore Volume and Area Distributions in Porous Substances. I. Computations from Nitrogen Isotherms , 1951 .